This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
This was a retrospective cohort study where the medical records and billing data from a single centre in Pennsylvania (USA) were reviewed. The attending physician chose the intervention. Charts were reviewed for complications up to 10 days after the procedure. A single reviewer evaluated the medical records. It was not reported whether the reviewer was blinded.
Analysis of effectiveness
The analysis in this observational study was performed on the basis of all included patients. The primary health outcomes were not specifically reported, but they included mainly major and minor complications. Differences among the groups (e.g. gender, age, number of days intubated before the tracheotomy) were not adjusted for in the analysis.
Effectiveness results
There were 3 complications (9%; 2 major) in the OT/OR group (n=29), 0 (0%) in the OT/BS group (n=14), and 8 (28%, contradictory report between text and table; 5 major) in the PDT group (n=28).
There was no statistically significant association between tracheotomy type or surgeon speciality and complications. There was a borderline association between complication rate and the number of days of intubation before the tracheotomy, (p=0.082).
There was no instance of loss of airway in any of the groups.
Four patients in the OT/OR group and one in the OT/BS died, although death was not attributed to tracheotomy complications.
Clinical conclusions
The authors concluded that the data from this study suggest that OT/OR, OT/BS and PDT are equally safe and effective procedures.
Measure of benefits used in the economic analysis
There was no summary measure of benefit. This was, in effect, a cost-consequences analysis.
Direct costs
Discounting was not performed, which was appropriate due to the short time horizon. Some quantities (e.g. procedure duration) were analysed for the OT groups, but most of the costs were calculated as an itemised charge per procedure, derived from the corresponding billing codes over two years. The costs items included surgeon fee, anaesthesia, bronchoscopy, equipment and OR cost/staff. Individual patient-specific charges were not included since the overall charge was frequently not itemised. An estimated deterministic cost per procedure was calculated. The price year was not specifically reported. The costs of complications were not included in the analysis.
